MBR regional market will be worth $280m in 2015
New report sees 'tremendous opportunities' in ME wastewater sector
A new report from Frost & Sullivan into the Membrane Bioreactor market has forecast that the market will be worth US $280.3 million in 2015. Covering municipal, commercial, residential and end-use sectors, the ‘Analysis of the Middle Eastern and North Africa (MENA) Membrane Bioreactor Market’ has said there are ‘untold opportunities’ within the region’s water and wastewater treatment sector.
“On an average, 50 per cent of Middle Eastern countries’ population is connected to wastewater networks. This creates tremendous opportunities for wastewater treatment and recycling technologies,” said Frost & Sullivan environmental industry manager, Sasidhar Chidanamarri.
Total water consumption in the Middle East is expected to grow to 319 billion cubic metres by 2020, boosted by agriculture, population and economic growth. As a result, economies around the region are expected to invest in urban water and sanitation infrastructure to “achieve Millennium Development Goals and lessen the reliance and deterioration of dwindling ground water resources.”
The region has been a leading adopter of new water and wastewater treatment technologies, with large capacity MBR systems treating domestic and industrial effluents already in place. At the same time, the report has warned that high costs of technology, negative perceptions of the wastewater reuse concept and poor collection and network infrastructure are hurdles to market penetration.
“Luring customers with cost-optimisation solutions is an effective means to gain market share. Strategic tie-ups with vendors of spares, chemical, and equipment will allow suppliers’ offerings to be cost effective. In the long run, associating with original equipment manufacturers will also be of immense value to membrane manufacturers to participate in new MBR projects, as well as to address replacement demand successfully,” added Chidanamarri.
The research says that tie-ups with EPC firms also represents a good method of creating stable demand for membrane-based products, and to promote MBRs, as EPC firms can recommend various technology options to their end users.